Featured Articles

  1. Meet A Project Ambassador - Michelle Ava

    Michelle has dedicated her career to simplifying organizational processes, making jobs easier and more efficient. Using a system of her own design, she mines data for relevant material to turn into reliable, actionable information to support executive team decision-making.

  2. Meet The Scientist — Dr. Peng Zhang

    While pursuing a career as a medical doctor, Peng Zhang realized there were limited treatments for patients suffering from a variety of diseases. She made the decision to fill that void by focusing on discovering and developing therapeutics.

  3. 5 Key Factors For A Successful Tech Transfer

    Each tech transfer comes with a unique set of complex processes that need to be understood. While it includes the transfer of analytical methods and manufacturing processes, there is also a human dimension to consider.

  4. Understanding Emergency Use Authorization (EUA)

    Emergency Use Authorization (EUA) is a term that became part of the COVID-19 daily news briefings. What exactly is EUA? When is it used? How do the public health community, FDA, and drug developers authorize emergency use of drugs or other medical products?

  5. Vaccine Capacity Musical Chairs

    In the past six months, I’ve spoken to more vaccine developers than I have in the previous eight years, all of them searching for production capacity. Has the music stopped? Is it time to grab a chair?

  6. Developing An Effective Lyophilization Cycle 9/20/2022

    Learn how and why a contract manufacturing and development organization (CDMO) that specializes in lyophilization relies on freeze drying systems.

  7. Enhancing Oral Solid Dose Solubility And Bioavailability With ASD

    Spray-dried ASD (amorphous solid dispersions) technology may be the catalyst needed to overcome solubility and bioavailability challenges for your promising oral solid dose candidate. 

  8. CDMO Innovation For The Future Pharmaceutical Supply Chain

    We have a longstanding mantra, “challenges frame opportunities.” This applies to how we intentionally innovate, modernize, and introduce new capabilities and expand capacity.

  9. Innovative Therapies Supporting 503B Of The Federal Food, Drug, And Cosmetic Act (FD&C Act) 11/24/2020

    Innovative therapies including customized, patient-specific compounds, are transforming healthcare, and presenting new challenges for pharmaceutical development, manufacturing, and supply chain management. Our healthcare ecosystem is experiencing tectonic shifts and providing a reliable supply of safe and effective medicines for hospitals and clinics to use for their patients will require an innovative, problem-solving mindset.

  10. Navigating An Ever-Changing Landscape: The Role Of A CFO In A Private Equity Controlled Pharma Company

    The role of Chief Financial Officer for a small-to-mid size pharma company controlled by private equity is a challenging one, especially since pharma companies with limited internal resources often rely on CDMOs for support. Learn how these CFOs can use their CDMOs to be more successful.